GTBPGT Biopharma, Inc.

Nasdaq gtbiopharma.com


$ 3.35 $ 0.10 (3.29 %)    

Friday, 03-May-2024 12:36:42 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 3.3
$ 3.35
$ 0.00 x 0
$ 0.00 x 0
$ 3.35 - $ 3.35
$ 2.95 - $ 16.11
2,857
na
4.45M
$ 0.40
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-07-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 10-31-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-28-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-23-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 04-16-2021 12-31-2020 10-K
14 11-13-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-27-2020 12-31-2019 10-K
18 11-14-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-15-2019 03-31-2019 10-Q
21 03-29-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 03-01-2018 12-31-2017 10-K
26 11-14-2017 09-30-2017 10-Q
27 08-11-2017 06-30-2017 10-Q
28 04-28-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-10-2016 06-30-2016 10-Q
32 05-13-2016 03-31-2016 10-Q
33 03-30-2016 12-31-2015 10-K
34 11-13-2015 09-30-2015 10-Q
35 08-14-2015 06-30-2015 10-Q
36 05-14-2015 03-31-2015 10-Q
37 03-31-2015 12-31-2014 10-K
38 01-08-2015 12-31-2013 10-K
39 01-08-2015 03-31-2014 10-Q
40 01-08-2015 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 recap-gt-biopharma-q4-earnings
Recap: GT Biopharma Q4 Earnings
03/26/2024 21:15:06

 gt-biopharma-q4-eps-214-beats-270-estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(2.14) per share which beat the analyst consensus estimate of $(2.70) ...

 why-cutera-shares-are-trading-lower-by-over-26-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected four...

 gt-biopharma-shares-resume-trade
GT Biopharma Shares Resume Trade
02/05/2024 14:00:33

 gt-biopharma-q3-eps-006-beats-010-estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.10) ...

 hc-wainwright--co-reiterates-buy-on-gt-biopharma-maintains-5-price-target

HC Wainwright & Co. analyst Robert Burns reiterates GT Biopharma (NASDAQ:GTBP) with a Buy and maintains $5 price target.

 ef-hutton-reiterates-hold-on-gt-biopharma-maintains-2-price-target

EF Hutton analyst Tony Butler reiterates GT Biopharma (NASDAQ:GTBP) with a Hold and maintains $2 price target.

 gt-biopharma-q2-eps-005-beats-010-estimate

GT Biopharma (NASDAQ:GTBP) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.10) ...

 why-state-street-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers PainReform Ltd. (NASDAQ: PRFX) shares climbed 103% to $11.67. PainReform recently announced pricing of a $2.7 millio...

 why-aehr-test-systems-shares-are-trading-higher-here-are-20-stocks-moving-premarket

Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.

 why-thor-industries-shares-are-trading-higher-by-15-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Recruiter.com Group, Inc. (NASDAQ: RCRT) shares jumped 114% to $0.41. Recruiter.com signed a definitive agreement fo...

 hc-wainwright--co-reiterates-buy-on-gt-biopharma-maintains-5-price-target

HC Wainwright & Co. analyst Robert Burns reiterates GT Biopharma (NASDAQ:GTBP) with a Buy and maintains $5 price target.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION